Nxera Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4565?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,885,1362.1%
VC/PE Firms5,610,0006.24%
Hedge Funds7,296,4008.12%
Individual Insiders7,419,0988.25%
Institutions20,861,85223.2%
General Public46,828,62052.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 52.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.12%
Taiyo Pacific Partners L.P.
7,296,400JP¥7.6b14.6%4.19%
7.37%
Daisuke Gomi
6,630,000JP¥6.9b0%no data
6.24%
JIC Venture Growth Investments Co., Ltd.
5,610,000JP¥5.9b0%no data
4.32%
Capital Research and Management Company
3,885,702JP¥4.1b0%no data
3.34%
Nomura Asset Management Co., Ltd.
3,004,300JP¥3.1b13.5%0.01%
3.32%
The Vanguard Group, Inc.
2,982,900JP¥3.1b0.09%no data
2.6%
Asset Management One Co., Ltd.
2,340,800JP¥2.5b0%0.02%
2.51%
JPMorgan Chase & Co, Brokerage and Securities Investments
2,260,929JP¥2.4b-15.1%0.01%
2.1%
Pfizer Inc.
1,885,136JP¥2.0b0%no data
1.74%
Mitsubishi UFJ Asset Management Co., Ltd.
1,568,700JP¥1.6b-0.44%0.01%
1.74%
Daiwa Asset Management Co., Ltd.
1,565,300JP¥1.6b-2.03%0.01%
1.66%
Barclays PLC Private Banking & Investment Banking Investment
1,495,183JP¥1.6b0%0.01%
1.5%
Nikko Asset Management Co., Ltd.
1,348,700JP¥1.4b-1.81%no data
1.45%
JP Morgan Asset Management
1,303,300JP¥1.4b0%no data
1.1%
SBI Holdings Inc., Asset Management Arm
991,837JP¥1.0b0%0.39%
0.99%
Norges Bank Investment Management
887,339JP¥929.9m0%no data
0.66%
Shinichi Tamura
594,270JP¥622.8m0%no data
0.42%
Goldman Sachs Asset Management, L.P.
375,600JP¥393.6m0%no data
0.19%
Schroder Investment Management North America Inc.
173,300JP¥181.6m44.5%no data
0.18%
Wellington Management Group LLP
162,276JP¥170.1m-1.4%no data
0.18%
Charles Schwab Investment Management, Inc.
157,536JP¥165.1m7.07%no data
0.16%
Coeli AB
144,555JP¥151.5m0%0.05%
0.14%
State Street Global Advisors, Inc.
127,100JP¥133.2m-0.31%no data
0.12%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
110,000JP¥115.3m0%no data
0.092%
Mizuho Financial Group, Inc., Asset Management Arm
82,985JP¥87.0m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 01:31
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nxera Pharma Co., Ltd. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Koichi MameganoBofA Global Research
Hidemaru YamaguchiCitigroup Inc
null nullCredit Suisse